Primary tumor (n = 50) | Recurrent tumor (n = 17) | |
---|---|---|
Sex | ||
Male | 34 | 12 |
Female | 16 | 5 |
Median age in years (range) | 61 (19–76) | 50 (19–66) |
Site of primary disease | ||
Extremity | 30 | 10 |
Trunk | 19 | 7 |
Head & Neck | 1 | 0 |
Site of recurrent disease | NA | |
Local | 8 | |
Distant | 9 | |
Histology | ||
Undifferentiated pleomorphic sarcoma (UPS) | 32 | 6 |
Leiomyosarcoma (LMS) | 6 | 1 |
Liposarcoma (LPS) | 6 | 1 |
Synovial sarcoma (SS) | 3 | 4 |
Malignant peripheral nerve sheath tumor (MPNST) | 2 | 3 |
Fibrosarcoma (FS) | 1 | 2 |
Prior treatment | ||
Gemcitabine/docetaxel | 27 | 2 |
Doxorubicin/ifosfamide | 17 | 1 |
Doxorubicin/dacarbazine | 0 | 1 |
None | 7 | 13 |
Radiation | 2 | 0 |